How HPLC Enables Reliable Thalassemia Detection During HbA1c Analysis
Ion-exchange HPLC utilizes isoelectric point differences to resolve:
HbA1c: Glycated HbA
HbA0: Non-glycated adult hemoglobin
HbA2: δ-chain variant, elevated in β-thalassemia trait
HbF: Fetal hemoglobin, often raised in β-thalassemia or hereditary persistence of fetal hemoglobin
Common variants: HbS, HbE, HbD, etc.
In standard “fast” HbA1c modes, subtle elevations may be overlooked. Dedicated Thalassemia Mode extends run time for higher resolution, allowing precise quantification in one seamless analysis.
Evidence from Clinical Studies
Incidental detection of variants and thalassemia traits occurs in 0.7% or more of routine HbA1c runs using HPLC, with careful chromatogram review preventing misreporting.
β-thalassemia minor can cause discordantly low HbA1c with abnormal chromatograms; HPLC flags these for further investigation (e.g., genetic testing).
In high-prevalence settings, combined HbA1c + HbA2/HbF reporting improves carrier screening efficiency and ensures diabetes management remains evidence-based.
NGSP and IFCC standardization ensures results are traceable to DCCT/UKPDS outcomes, while HPLC’s visual chromatogram allows laboratorians to review peaks and apply flags (e.g., variant risk alerts).
Goldsite GSH-50 & GSH-60: Triple-Mode Excellence for Integrated Diagnostics
Our NGSP/IFCC-certified HPLC analyzers are purpose-built for real-world laboratories serving diverse populations: